Due to network maintenance at the University of Basel, the SWISS-MODEL website will be interrupted this weekend between 07:00 CET Saturday 17th May and 23:55 CET Sunday 18th May.

Multiple Assemblies exist for SMTL entry 6ibf
Crystal structure of human phosphodiesterase 4D2 catalytic domain with inhibitor NPD-417; X-RAY DIFFRACTION 2.31 Å

SMTL ID
6ibf.1
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; (4~{a}~{S},8~{a}~{R})-4-[4-methoxy-3-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]-2-(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6ibf.2
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; (4~{a}~{S},8~{a}~{R})-4-[4-methoxy-3-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]-2-(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6ibf.3
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; (4~{a}~{S},8~{a}~{R})-4-[4-methoxy-3-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]-2-(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer
SMTL ID
6ibf.4
Ligands
ZINC ION; MAGNESIUM ION; 1,2-ETHANEDIOL; DI(HYDROXYETHYL)ETHER; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID; (4~{a}~{S},8~{a}~{R})-4-[4-methoxy-3-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]-2-(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one
Polypeptides
cAMP-specific 3',5'-cyclic phosphodiesterase 4D
Oligo-state
monomer